Children with later-onset spinal muscular atrophy (SMA) were more likely to show gains in motor function when treated with a new medication compared to children receiving a sham procedure, according to a study published today in the New England Journal of Medicine. The study demonstrates the impact the drug, nusinersen, can have on older patients with this progressive neuromuscular disorder.
Fifty-three percent of parents who receive their child's body mass index (BMI) report card do not believe that it accurately categorizes their child as underweight, normal weight, overweight, or obese, according to research out today in Health Promotion Practice, a SAGE Publishing journal.
An analysis by investigators from MassGeneral Hospital for Children and Newton-Wellesley Hospital of trends in sudden unexpected infant death finds that the drop in such deaths that took place following release of the 1992 American Academy of Pediatrics 'back to sleep' recommendations, did not occur in infants in the first month of life.
Vitamin D deficiency in pregnant women could preprogram babies to grow into obese children and adults, according to a Keck School of Medicine of USC-led study. Researchers found that 6-year-olds born to mothers with very low vitamin D levels during their first trimester had bigger waists -- about half an inch plumper on average -- than peers whose mothers had enough vitamin D in early pregnancy. These kids also had 2 percent more body fat.
One of the greatest health threats to children with sickle cell anemia is getting a dangerous bacterial infection -- but most are not receiving a key medication to reduce the risk, a new study suggests.
The dependent coverage provision of the Affordable Care Act (ACA) that allowed young adults to stay on their parents' insurance until they were 26 was associated with increased use of prenatal care, increased private insurance payment for births, and a modest reduction in preterm births.
A new study from Sweden found that social benefits often ease the financial burdens experienced by the parents of children recently diagnosed with cancer, but mothers experienced persistently lower income after benefits diminished. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that additional efforts may be needed to address the financial hardships experienced by the mothers of children with cancer.
Levetiracetam, the most commonly prescribed drug for US infants with epilepsy, may be significantly more effective than the second-choice drug phenobarbital, according to a new study by scientists from Weill Cornell Medicine, NewYork-Presbyterian and 16 other research institutions. The findings provide the first evidence to favor levetiracetam in infants.
With states rapidly legalizing cannabis for medicinal and recreational use, physicians will be increasingly pressed to counsel patients on their frequency of use and dosage, as well as associated risks. The special report in the JAOA aggregates what is known to help physicians give the best evidence-based recommendations.
Levetiracetam was found to be superior to phenobarbital as initial monotherapy for infants with nonsyndromic epilepsy.